December 11, 2022

Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA antibody Tifcemalimab in Treatment of Relapsed/Refractory Lymphomas at 64th ASH Annual Meeting

December 11, 2022

— Preliminary study results show that tifcemalimab is well-tolerated at all administered doses. The observed clinical activity of tifcemalimab in combination with toripalimab in lymphoma patients refractory to checkpoint inhibitors warrants further evaluation. Combination dose expansion is under way. — Among the 28 evaluable patients who received the combination regimen,

KMT’s Wang questions DPP rival Enoch Wu’s Songshan Airport plans

December 11, 2022

Wang Hung-wei (???), the Kuomintang (KMT) candidate for January’s legislative by-election in Taipei, on Sunday questioned the feasibility of Democratic Progressive Party (DPP) rival Enoch Wu’s (???) proposal to transform Songshan Airport into a public …

Japan ruling party’s senior member supports Taiwan’s CPTPP bid

December 11, 2022

A visiting senior member of Japan’s ruling party on Sunday expressed his support for Taiwan’s bid to join a Tokyo-led trade bloc, but raised concerns over the nation’s partial ban on some Japanese food imports, calling for its removal as soon as possib…

Taiwan, Czechia ink MOU to foster cultural exchange

December 11, 2022

The National Museum of Taiwan Literature (NMTL) and the Moravian Library of the Czech Republic have signed a memorandum of understanding (MOU) aimed at boosting bilateral collaboration with a focus on culture and literature.The MOU, which was inked thr…

Support Thailand-Nanning Create opportunities for the automotive-energy industry

April 23, 2024

Krung Thai advises businesses to accelerate adoption of the circular economy model. Create opportunities to increase income and reduce costs.

April 23, 2024

Government and private sector join hands ‘Don’t sign the copy. Do not call for documents to support businesses and citizens

April 23, 2024

Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA antibody Tifcemalimab in Treatment of Relapsed/Refractory Lymphomas at 64th ASH Annual Meeting

KMT’s Wang questions DPP rival Enoch Wu’s Songshan Airport plans

Japan ruling party’s senior member supports Taiwan’s CPTPP bid

Taiwan, Czechia ink MOU to foster cultural exchange

Recent News

Support Thailand-Nanning Create opportunities for the automotive-energy industry

Krung Thai advises businesses to accelerate adoption of the circular economy model. Create opportunities to increase income and reduce costs.

Thai stocks closed up 7.94 points.

SET is accepting applications for SET Manager until 30 April 2024.

MEA wins 4 awards in international innovation competition

Gold falls sharply, the baht weakens in more than 6 months.

mai welcomes Terabyte Plus Public Company Limited (TERA) to start trading on 24 April.

The private sector will try to hold on to products as long as possible even if costs increase.

Thai stocks closed this morning up 11.57 points.

Government and private sector join hands ‘Don’t sign the copy. Do not call for documents to support businesses and citizens

About

Taiwan Newswire is a dynamic and reliable news platform that delivers the latest updates and insights on various topics in Taiwan. With its commitment to accuracy and quality journalism, Taiwan Newswire has established itself as a go-to source for both local and international news.

Read more

Categories

Search

Pages